about
Effect of a novel cognition enhancer NS-105 on learned helplessness in rats: possible involvement of GABA(B) receptor up-regulation after repeated treatment.A comparison of Ca2+ channel blocking mode between gabapentin and verapamil: implication for protection against hypoxic injury in rat cerebrocortical slices.Effect of a single treatment with tadalafil on blood flow in lower urinary tract tissues in rat models of bladder overdistension/emptying and abdominal aorta clamping/release.Reduction in oxalate-induced renal tubular epithelial cell injury by an extract from Quercus salicina Blume/Quercus stenophylla Makino.Two types of prostacyclin receptor coupling to stimulation of adenylate cyclase and phosphatidylinositol hydrolysis in a cultured mast cell line, BNu-2cl3 cells.Release of endothelial nitric oxide in coronary arteries by celiprolol, a beta(1)-adrenoceptor antagonist: possible clinical relevance.Acamprosate {monocalcium bis(3-acetamidopropane-1-sulfonate)} reduces ethanol-drinking behavior in rats and glutamate-induced toxicity in ethanol-exposed primary rat cortical neuronal cultures.Bladder function in 17β-estradiol-induced nonbacterial prostatitis model in Wistar rat.Electrophysiological and neurochemical evidence for voltage-dependent Ca(2+) channel blockade by a novel neuroprotective agent NS-7.Halothane attenuates the cerebroprotective action of several Na+ and Ca2+ channel blockers via reversal of their ion channel blockade.Functional role of inhibitory and excitatory nerves in the porcine lower urinary tract.Tramadol enhances urethral continence function through µ-opioid receptors in rats.Functional expression of constitutive nitric oxide synthases regulated by voltage-gated Na+ and Ca2+ channels in cultured human astrocytes.Phosphodiesterase inhibition by a gastroprotective agent irsogladine: preferential blockade of cAMP hydrolysis.Irsogladine, an anti-ulcer drug, suppresses superoxide production by inhibiting phosphodiesterase type 4 in human neutrophils.Eviprostat suppresses urinary oxidative stress in a rabbit model of partial bladder outlet obstruction and in patients with benign prostatic hyperplasia.Suppression of bladder oxidative stress and inflammation by a phytotherapeutic agent in a rat model of partial bladder outlet obstruction.Inhibitions of urinary oxidative stress and renal calcium level by an extract of Quercus salicina Blume/Quercus stenophylla Makino in a rat calcium oxalate urolithiasis model.A comparison of vasodilation mode among selexipag (NS-304; [2-{4-[(5,6-diphenylpyrazin-2-yl)(isopropyl)amino]butoxy}-N-(methylsulfonyl)acetamide]), its active metabolite MRE-269 and various prostacyclin receptor agonists in rat, porcine and human puSuppression of bladder overactivity and oxidative stress by the phytotherapeutic agent, Eviprostat, in a rat model of atherosclerosis-induced chronic bladder ischemia.A novel cognition enhancer NS-105 modulates adenylate cyclase activity through metabotropic glutamate receptors in primary neuronal culture.Effects of the phosphodiesterase 5 inhibitor Tadalafil on bladder function in a rat model of partial bladder outlet obstruction.Involvement of Na+ and Ca2+ channel activation and resultant nitric oxide synthesis in glutamate-mediated hypoxic injury in rat cerebrocortical slices.Effect of the phytotherapeutic agent Eviprostat on inflammatory changes and cytokine production in a rat model of nonbacterial prostatitis.Protein kinases are involved in prolonged acetylcholine release from rat hippocampus induced by thyrotropin-releasing hormone analogue NS-3Prostacyclin (PGI) receptor binding and cyclic AMP synthesis activities of PGI1 analogues, SM-10906 and its methyl ester, SM-10902, in mastocytoma P-815 cellsDetermination and bioimaging method for nitric oxide in biological specimens by diaminofluorescein fluorometryRole of metabotropic glutamate receptor subclasses in modulation of adenylyl cyclase activity by a nootropic NS-105Involvement of peroxynitrite and hydroxyradical generated from nitric oxide in hypoxia/reoxygenation injury in rat cerebrocortical slicesPreferential inhibition by a novel Na(+)/Ca(2+) channel blocker NS-7 of severe to mild hypoxic injury in rat cerebrocortical slices: A possible involvement of a highly voltage-dependent blockade of Ca(2+) channelBlockade by NS-7, a neuroprotective compound, of both L-type and P/Q-type Ca2+ channels involving depolarization-stimulated nitric oxide synthase activity in primary neuronal cultureRelevance of anti-reactive oxygen species activity to anti-inflammatory activity of components of eviprostat, a phytotherapeutic agent for benign prostatic hyperplasiaEffect of tramadol on pain-related behaviors and bladder overactivity in rodent cystitis modelsEffect of a phytotherapeutic agent, Eviprostat®, on prostatic and urinary cytokines/chemokines in a rat model of nonbacterial prostatitisThe analgesic effect of tramadol in animal models of neuropathic pain and fibromyalgia[Pharmacological profiles and clinical roles of acamprosate (Regtect(®) tablets 333 mg) for the maintenance of abstinence in alcohol-dependent patients]Effect of tadalafil on chronic pelvic pain and prostatic inflammation in a rat model of experimental autoimmune prostatitisChronic pelvic pain and prostate inflammation in rat experimental autoimmune prostatitis: Effect of a single treatment with phosphodiesterase 5 inhibitors on chronic pelvic pain
P50
Q34451665-BC7184A3-024E-4DC5-8FB3-DC5329EFAB04Q35045305-924D943E-6C78-4E25-B32B-0F576A81BEA2Q35564203-9F7A46AB-30A2-476D-A55A-782422EF3C6EQ40078121-EEDBF6BD-B62D-4F14-9B31-EDE6F3403422Q41532756-4610D368-5512-48EF-BD10-6C87EE2EEE5CQ43557396-04E23399-CD6E-46B2-95F4-DAE7AC25614BQ43580058-0DFE441D-C12F-45A6-9DB7-F7F1762A7D3CQ43689907-B91866E3-A759-4B16-9413-03F1D1E19BC2Q43758768-232E43B5-52AC-483F-9478-AA5CEBCB25F1Q44158803-3EC72B36-1E5E-4DDA-B054-2FFA6B28546FQ44228311-209A1390-74CB-4D69-976A-744A8D422A29Q44334500-E9064357-9679-47F1-B60A-A8ADAF94423AQ44786005-9A735643-9557-4CC9-9B60-A9959C57CD83Q45012150-42F77C7F-42E6-4268-B820-7C8D783CD7D2Q45121605-F90028B6-9DF2-4BF1-81D4-D80DBE43B74CQ45935910-7DE49D6E-AC7C-4B77-B135-203DF093213CQ46008844-86E5BB54-8ABA-4D18-99DA-75E2A45376AEQ46020444-DF0C168E-8684-4468-9219-54006E2B414AQ46450160-52DC8FF0-B6A3-4A19-9599-8A8E507298EDQ48174458-F84302FB-DABB-436E-8F5F-BBE786102E06Q48647681-E6509662-F6A2-4077-B257-57311B40A453Q51052878-2435F154-151C-4454-B569-DC8DB86B0460Q51373328-EA3FB2C4-B10E-4519-9A92-739AC41C9FDCQ53244256-E5F7A954-1849-49E3-A086-0B1C33996249Q71464514-8A638025-8B05-4047-922F-2D1BFED18D9DQ71617078-EAFA708E-DC7A-43F3-8867-3E54AA015C06Q73286652-AB7FBADB-8BAA-4B15-9A9D-7FF8C4DE00DDQ73349053-8D88A0A9-6E97-445C-884E-EF0299FDF9D5Q73665689-98F6BCB9-386E-4733-8849-81C3DD0C560FQ73693249-A1B8E2D9-6700-43D7-9A18-349770D42009Q74484859-03844680-DC61-4DAD-B3E0-DDDCE1A9A259Q80510105-6A5C8D50-20FE-4B0B-A4D5-2C8689007517Q83130485-B74C5D70-D56F-46FE-97E8-0A3041EFF244Q83258928-E1FCEDCB-D548-4C11-B35F-6ACA332C72F1Q87074767-AB009717-E4BD-4B9E-851F-DB2BA499BF57Q87373673-AAA44394-931E-45CA-A70D-CD8BCD2FD4FCQ88169878-A7373502-BAFD-4C8E-821D-04C9324E5D47Q90226819-38736575-9E08-4CCF-B491-B331EAA5F56A
P50
description
researcher ORCID ID = 0000-0003-1581-400X
@en
wetenschapper
@nl
name
Michiko Oka
@ast
Michiko Oka
@en
Michiko Oka
@es
Michiko Oka
@nl
type
label
Michiko Oka
@ast
Michiko Oka
@en
Michiko Oka
@es
Michiko Oka
@nl
prefLabel
Michiko Oka
@ast
Michiko Oka
@en
Michiko Oka
@es
Michiko Oka
@nl
P108
P1153
7403144031
P31
P496
0000-0003-1581-400X